# Curosurf/Budesonide for Infants With Respiratory Distress Syndrome

> **NCT02013115** · NA · COMPLETED · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 300 (actual)

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT02013115
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2017-10-30
- **Final completion:** 2017-10-30
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02013115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02013115, "Curosurf/Budesonide for Infants With Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02013115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*